CASE REPORT article

Front. Oncol.

Sec. Surgical Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1597194

Phosphaturic Mesenchymal Tumor Presenting Solely as Knee Pain without Hypophosphatemia: A Case Report

Provisionally accepted
  • People's Hospital of Zhengzhou University, Zhengzhou, China

The final, formatted version of the article will be published soon.

Phosphaturic mesenchymal tumor (PMT) is a rare tumor disease that often leads to tumor-induced osteomalacia (TIO). The typical manifestations of this disease include hypophosphatemia and osteomalacia. The main symptom in most PMT patients is diffuse pain throughout the body. However, we report a PMT patient with typical histological features but without hypophosphatemia and TIO. This patient only presented with pain in the right knee joint. At 6 months and 1 year after surgery, follow -up revealed that the patient's swelling and pain in the right knee joint had disappeared.Moreover, the imaging and biochemical examinations conducted at the local hospital showed normal results.

Keywords: Phosphaturic mesenchymal tumors, Tumor-induced osteomalacia, Fibroblast growth factor 23, Pain, Hypophosphatemia, Osteomalacia

Received: 25 Mar 2025; Accepted: 16 Apr 2025.

Copyright: © 2025 Cao, Cheng and Dai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Zhipeng Dai, People's Hospital of Zhengzhou University, Zhengzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more